FDA’s top vaccine regulator single-handedly rejected Moderna’s flu shot application over a trial design the agency had previously approved, overruling career scientists who wrote a formal objection.
9th company to receive suprise rejection
Read the full story at Ars Technica
From the February 12, 2026 GovBrief, every story that day in one place.
